Gene · 9123
Papers3,520
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,520
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glycolysis‑driven immunosuppression in gastric cancer: Metabolic crosstalk between tumor cells and the immune microenvironment (Review). | Int J Oncol | 2026 | 42429073 | PubTator, text mining | PubMed |
| Integrative Transcriptomics Across Etiologies Reveals Common and Disease-Specific Fibrogenic Signatures in Liver Fibrosis. | Can J Gastroenterol Hepatol | 2026 | 42415271 | PubTator, text mining | PubMed |
| Beyond a waste product: lactate as a master metabolite dictating anti-tumor T-cell fate. | Cell Death Dis | 2026 | 42337227 | PubTator, text mining | PubMed |
| A pH-responsive liposomal nanoplatform for reprogramming lactate metabolism and immunogenic activation in pancreatic cancer. | Biomaterials | 2026 | 42335581 | PubTator, text mining | PubMed |
| A juglone derivative that disrupts mitochondrial redox metabolism, inhibiting the breast fibroblast-cancer cell pro-migratory signaling induced by doxorubicin. | Biomed Pharmacother | 2026 | 42320365 | PubTator, text mining | PubMed |
| Nano-enabled spatially selective protein degradation modulates lactate metabolism to potentiate antitumor immunity in liver cancer. | Nat Nanotechnol | 2026 | 42298103 | PubTator, text mining | PubMed |
| Beyond cartilage degeneration: osteoarthritis as a systems failure of inflammation regulation. | Front Med (Lausanne) | 2026 | 42292186 | PubTator, text mining | PubMed |
| Phenylalanine Versus Tyrosine (Pos. 367/332 in MCT1/MCT4) in the Substrate Binding Site Defines Affinity and Preferred Directionality of Human Monocarboxylate Transporters 1-4. | Acta Physiol (Oxf) | 2026 | 42289603 | PubTator, text mining | PubMed |
| Intracranial Human BT12 Glioblastoma Xenograft is [18F]FET PET Negative but 6-[18F]Fluoronicotinic Acid PET Positive: Exploring a Novel Approach for Clinical Glioblastoma Imaging. | Mol Pharm | 2026 | 42261079 | PubTator, text mining | PubMed |
| Model epithelia from rumen organoids. | Am J Physiol Cell Physiol | 2026 | 42227983 | PubTator, text mining | PubMed |
| Acidic Tumor Microenvironment Promotes 5-Fluorouracil Resistance Via Lactate-Driven HIF-1α/MCT4 Activation and Epigenetic Remodeling in Gastric Cancer. | Anticancer Agents Med Chem | 2026 | 42227488 | PubTator, text mining | PubMed |
| Metabolic-epigenetic crosstalk in lung cancer: Glycolytic reprogramming and lactylation-driven macrophage polarization. | Pathol Res Pract | 2026 | 42214873 | PubTator, text mining | PubMed |
| Syrosingopine enhances immune checkpoint blockade efficacy by inhibition of MCTs and metabolic reprogramming in triple-negative breast cancer. | Biochim Biophys Acta Mol Basis Dis | 2026 | 42202910 | PubTator, text mining | PubMed |
| Integrin-binding sialoprotein as an extracellular matrix-associated independent prognostic biomarker in glioma. | BMC Cancer | 2026 | 42192542 | PubTator, text mining | PubMed |
| Aerobic glycolysis-driven lactate accumulation and acidic tumor microenvironment in hepatocellular carcinoma: a vicious cycle promoting tumor progression. | Front Pharmacol | 2026 | 42181875 | PubTator, text mining | PubMed |
| Traditional Chinese medicine reverses immune checkpoint resistance through lactate metabolic reprogramming in hepatocellular carcinoma: Mechanisms and therapeutic implications. | J Ethnopharmacol | 2026 | 42178078 | PubTator, text mining | PubMed |
| Repurposing Syrosingopine for Cancer Therapy: Lactate Trapping and ISR Sensitization as Metabolic Vulnerabilities. | Oncol Ther | 2026 | 42171986 | PubTator, text mining | PubMed |
| Metabolic crosstalk in the bladder tumor microenvironment: lactate shuttling, amino acid dependency, and immunosuppression. | Cytotechnology | 2026 | 42145840 | PubTator, text mining | PubMed |
| Proteotoxic Stress Triggers Autophagy-Mediated AS160 Degradation and Metabolic Reprogramming in Colorectal Cancer. | ACS Omega | 2026 | 42110819 | PubTator, text mining | PubMed |
| Proteomic and Metabolomic Profiling Reveal Mitochondrial Transplantation-Mediated Reprogramming in Gastric Cancer Cells. | Kaohsiung J Med Sci | 2026 | 42099017 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9123/papers?page=2